Alyeska-Investment-Group-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
492
Total Value
25057785470
Accession Number
0001172661-25-002312
Form Type
13F-HR
Manager Name
Alyeska-Investment-Group-Lp
Data Enrichment
96% identified
470 identified22 unidentified

Holdings

492 positions • $25.1B total value
Manager:
Search and click to pin securities to the top
Page 25 of 25
ROKU, INC
Shares:4.3K
Value:$301.6K
% of Portfolio:0.0% ($301.6K/$25.1B)
Artiva Biotherapeutics, Inc.
Shares:100.0K
Value:$300.0K
% of Portfolio:0.0% ($300.0K/$25.1B)
Akebia Therapeutics, Inc.
Shares:134.3K
Value:$257.8K
% of Portfolio:0.0% ($257.8K/$25.1B)
Werewolf Therapeutics, Inc.
Shares:235.7K
Value:$229.2K
% of Portfolio:0.0% ($229.2K/$25.1B)
Nautilus Biotechnology, Inc.
Shares:253.5K
Value:$218.2K
% of Portfolio:0.0% ($218.2K/$25.1B)
G01558116
Shares:20.8K
Value:$212.8K
% of Portfolio:0.0% ($212.8K/$25.1B)
Septerna, Inc.
Shares:35.0K
Value:$202.7K
% of Portfolio:0.0% ($202.7K/$25.1B)
ROCKET PHARMACEUTICALS, INC.
Shares:30.3K
Value:$202.2K
% of Portfolio:0.0% ($202.2K/$25.1B)
Traws Pharma, Inc.
Shares:52.6K
Value:$121.0K
% of Portfolio:0.0% ($121.0K/$25.1B)
Surrozen, Inc./DE
Shares:10.2K
Value:$118.8K
% of Portfolio:0.0% ($118.8K/$25.1B)
B5950S113
Shares:70.3K
Value:$99.8K
% of Portfolio:0.0% ($99.8K/$25.1B)
InflaRx N.V.
Shares:13.5K
Value:$13.8K
% of Portfolio:0.0% ($13.8K/$25.1B)